BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mohamed A, El-Rayes B, Khuri FR, Saba NF. Targeted therapies in metastatic esophageal cancer: advances over the past decade. Crit Rev Oncol Hematol. 2014;91:186-196. [PMID: 24582516 DOI: 10.1016/j.critrevonc.2014.01.010] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
Number Citing Articles
1 Yang PW, Liu YC, Chang YH, Lin CC, Huang PM, Hua KT, Lee JM, Hsieh MS. Cabozantinib (XL184) and R428 (BGB324) Inhibit the Growth of Esophageal Squamous Cell Carcinoma (ESCC). Front Oncol 2019;9:1138. [PMID: 31781483 DOI: 10.3389/fonc.2019.01138] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
2 Liao Z, Wang X, Liang H, Yu A, Ur Rehman U, Fan Q, Hu Y, Wang C, Zhou Z, Wang T. miR-1 suppresses the proliferation and promotes the apoptosis of esophageal carcinoma cells by targeting Src. Cancer Med 2017;6:2957-65. [PMID: 29034995 DOI: 10.1002/cam4.1214] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
3 Chen GZ, Zhu HC, Dai WS, Zeng XN, Luo JH, Sun XC. The mechanisms of radioresistance in esophageal squamous cell carcinoma and current strategies in radiosensitivity. J Thorac Dis 2017;9:849-59. [PMID: 28449496 DOI: 10.21037/jtd.2017.03.23] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 4.8] [Reference Citation Analysis]
4 Zhou F, Yu X, Liang P, Cheng Z, Han Z, Yu J, Liu F, Tan S, Dai G, Bai L. Combined microwave ablation and systemic chemotherapy for liver metastases from oesophageal cancer: Preliminary results and literature review. International Journal of Hyperthermia 2016;32:524-30. [DOI: 10.3109/02656736.2016.1155758] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
5 Zhao W, Zhao J, Kang L, Li C, Xu Z, Li J, Zhang M. Fluoroscopy-Guided Salvage Photodynamic Therapy Combined with Nanoparticle Albumin-Bound Paclitaxel for Locally Advanced Esophageal Cancer after Chemoradiotherapy: A Case Report and Literature Review. Cancer Biother Radiopharm 2021. [PMID: 33794100 DOI: 10.1089/cbr.2020.4595] [Reference Citation Analysis]
6 Cao B, Yang W, Jin Y, Zhang M, He T, Zhan Q, Herman JG, Zhong G, Guo M. Silencing NKD2 by Promoter Region Hypermethylation Promotes Esophageal Cancer Progression by Activating Wnt Signaling. Journal of Thoracic Oncology 2016;11:1912-26. [DOI: 10.1016/j.jtho.2016.06.015] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
7 Kim EJ, Kim JH, Song HJ, Park SR, Kim YH, Kim HR, Kim SB. Impact of sequential lines of palliative chemotherapy in patients with recurrent/metastatic esophageal squamous cell carcinoma: A retrospective analysis of 107 patients at a single center. Asia Pac J Clin Oncol 2020;16:e53-62. [PMID: 31657877 DOI: 10.1111/ajco.13283] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Zhou L, Luo W. Vascular endothelial growth factor-targeted paclitaxel-loaded liposome microbubbles and inhibition of human epidermoid-2 cell proliferation. Head Neck 2017;39:656-61. [PMID: 28106938 DOI: 10.1002/hed.24648] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
9 Yang XX, Ma M, Sang MX, Zhang XY, Zou NY, Zhu SC. Knockdown of FAM83D Enhances Radiosensitivity in Coordination with Irradiation by Inhibiting EMT via the Akt/GSK-3β/Snail Signaling Pathway in Human Esophageal Cancer Cells. Onco Targets Ther 2020;13:4665-78. [PMID: 32547096 DOI: 10.2147/OTT.S245681] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Du Y, Lu F, Li P, Ye J, Ji M, Ma D, Ji C. SMG1 acts as a novel potential tumor suppressor with epigenetic inactivation in acute myeloid leukemia. Int J Mol Sci 2014;15:17065-76. [PMID: 25257528 DOI: 10.3390/ijms150917065] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
11 He SL, Wang WP, Yang YS, Li EM, Xu LY, Chen LQ. FAM3B promotes progression of oesophageal carcinoma via regulating the AKT-MDM2-p53 signalling axis and the epithelial-mesenchymal transition. J Cell Mol Med 2019;23:1375-85. [PMID: 30565387 DOI: 10.1111/jcmm.14040] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
12 Tang X, Zhou X, Li Y, Tian X, Wang Y, Huang M, Ren L, Zhou L, Ding Z, Zhu J, Xu Y, Peng F, Wang J, Lu Y, Gong Y. A Novel Nomogram and Risk Classification System Predicting the Cancer-Specific Survival of Patients with Initially Diagnosed Metastatic Esophageal Cancer: A SEER-Based Study. Ann Surg Oncol 2019;26:321-8. [DOI: 10.1245/s10434-018-6929-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 4.5] [Reference Citation Analysis]
13 Zeng J, Kelbauskas L, Rezaie A, Lee K, Ueberroth B, Gao W, Derkach D, Tran T, Smith D, Bussey KJ, Meldrum DR. Transcriptional regulation by normal epithelium of premalignant to malignant progression in Barrett's esophagus. Sci Rep 2016;6:35227. [PMID: 27731371 DOI: 10.1038/srep35227] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
14 Hsu HS, Lin MH, Jang YH, Kuo TT, Liu CC, Cheng TH. The 4E-BP1/eIF4E ratio is a determinant for rapamycin response in esophageal cancer cells. J Thorac Cardiovasc Surg 2015;149:378-85. [PMID: 25439783 DOI: 10.1016/j.jtcvs.2014.09.047] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
15 Zhang L, Yao M, Yan W, Liu X, Jiang B, Qian Z, Gao Y, Lu XJ, Chen X, Wang QL. Delivery of a chemotherapeutic drug using novel hollow carbon spheres for esophageal cancer treatment. Int J Nanomedicine 2017;12:6759-69. [PMID: 28932119 DOI: 10.2147/IJN.S142916] [Cited by in Crossref: 19] [Cited by in F6Publishing: 4] [Article Influence: 3.8] [Reference Citation Analysis]
16 Ren C, Zhou Z, Wang X, Hua X, Zou M, Zhang X. SHCBP1 Promotes the Progression of Esophageal Squamous Cell Carcinoma Via the TGFβ Pathway. Appl Immunohistochem Mol Morphol 2021;29:136-43. [PMID: 32769441 DOI: 10.1097/PAI.0000000000000858] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Wang XW, Shi XH, Tong YS, Cao XF. The Prognostic Impact of Heat Shock Proteins Expression in Patients with Esophageal Cancer: A Meta-Analysis. Yonsei Med J. 2015;56:1497-1502. [PMID: 26446629 DOI: 10.3349/ymj.2015.56.6.1497] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
18 Pendleton EG, Jamasbi RJ, Geusz ME. Tetrahydrocurcumin, Curcumin, and 5-Fluorouracil Effects on Human Esophageal Carcinoma Cells. ACAMC 2019;19:1012-20. [DOI: 10.2174/1871520619666190116141448] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
19 Bennett M, Mashimo H. Molecular markers and imaging tools to identify malignant potential in Barrett's esophagus. World J Gastrointest Pathophysiol 2014; 5(4): 438-449 [PMID: 25400987 DOI: 10.4291/wjgp.v5.i4.438] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
20 Yoshioka M, Ohashi S, Ida T, Nakai Y, Kikuchi O, Amanuma Y, Matsubara J, Yamada A, Miyamoto S, Natsuizaka M, Nakagawa H, Chiba T, Seno H, Muto M. Distinct effects of EGFR inhibitors on epithelial- and mesenchymal-like esophageal squamous cell carcinoma cells. J Exp Clin Cancer Res 2017;36:101. [PMID: 28764725 DOI: 10.1186/s13046-017-0572-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
21 Pi J, Jin H, Jiang J, Yang F, Cai H, Yang P, Cai J, Chen ZW. Single molecule force spectroscopy for in-situ probing oridonin inhibited ROS-mediated EGF-EGFR interactions in living KYSE-150 cells. Pharmacol Res 2017;119:479-89. [PMID: 28411855 DOI: 10.1016/j.phrs.2016.11.036] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 4.6] [Reference Citation Analysis]
22 Yue GG, Li L, Lee JK, Kwok HF, Wong EC, Li M, Fung KP, Yu J, Chan AW, Chiu PW, Lau CB. Multiple modulatory activities of Andrographis paniculata on immune responses and xenograft growth in esophageal cancer preclinical models. Phytomedicine 2019;60:152886. [PMID: 30910259 DOI: 10.1016/j.phymed.2019.152886] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
23 Zhu DS, Dong JY, Xu YY, Zhang XT, Fu SB, Liu W. Omipalisib Inhibits Esophageal Squamous Cell Carcinoma Growth Through Inactivation of Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) and ERK Signaling. Med Sci Monit 2020;26:e927106. [PMID: 32804918 DOI: 10.12659/MSM.927106] [Reference Citation Analysis]
24 Bonhin RG, Rocha VB, Carvalho GM, Guimarães AC, Crespo AN, Chone CT, Amstalden EM. Correlation between vascular endothelial growth factor expression and presence of lymph node metastasis in advanced squamous cell carcinoma of the larynx. Braz J Otorhinolaryngol 2015;81:58-62. [PMID: 25595850 DOI: 10.1016/j.bjorl.2014.08.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]